The MNC Collab – 34 - SC project approach requires the systemic administration of a proprietary gene editing complex. This complex will target progenitor cells within the peripheral blood and bone mar...
Jenthera Therapeutics inc.
7 enregistrements totalisant 780,262.75 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Conseil national de recherches Canada | $780,263 | 7 enregistrements |
Enregistrements
Using a known oncogene as the target, this project will aim at generating a proof of concept in animal for a novel gene editing therapeutic platform. Using a proprietary targeting mechanism, prior to...
The project will focus on developing a suite of gene editing complexes capable of delivering gene edits in vivo to specific cell types. The goal is to modify, correct, or enhance cell behaviors, enabl...
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small and medium-sized enterprises that are unable to access existing COVID-19 business support.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Rese...
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.